HHS released a policy roadmap for providers ahead of the public health emergency (PHE) conclusion. The roadmap details policies that will simultaneously end with the PHE, as well as flexibilities that have been extended for various time periods.
A federal judge remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program. After experiencing several key wins throughout their long legal battle with HHS, the American Hospital Association and other industry plaintiffs were disappointed by the ruling.
NAHRI has extended the deadline to submit application to speak at the 2023 Revenue Integrity Symposium (RIS), to be held September 18‒19 in Charlotte, North Carolina. The deadline to submit applications is Sunday, January 29.
More payers and providers are using the independent dispute resolution (IDR) process than the government anticipated to settle payment for items and services covered by the No Surprises Act.